|
"Covidien and Sleep Pointe believe that accessible treatment to the disorder can prevent some fatalities on the road.
"Every 16 minutes in America, somebody is killed or injured in a truck-related accident and we know that at the core of those accidents often is sleep deprivation or a trucker being fully asleep behind the wheel," he said. |
|
|
“Sleep Pointe’s impressive sleep disorder solution enhances CIRCADIAN’s fatigue risk management system and offers significant value to all 24/7 operations. When obstructive sleep apnea is effectively treated, companies see a 50% reduction in accidents and injuries and a 70% reduction in health care costs in this very expensive group of employees,” says Martin Moore-Ede, MD, PhD, CEO of CIRCADIAN.
Read More in Sleep Review/The Journal for Sleep Specialsts |
|
Circadian said Sleep Pointe has the “unique ability to create a customized program that ultimately provides standardized, uniform sleep apnea solutions for their customers--anytime, anywhere. By using specially equipped trucks and mobile units, delivering temporary clinical setups in hotels and other facilities, and providing over 50 fixed sites, Sleep Pointe has established the first sleep apnea treatment solution tailored specifically to the needs of the transportation industry.” Read More in FleetOwner |
|
"Sleep apnea is a big health problem among truckers, but many have trouble scheduling the overnight sleep study that is vital to an accurate diagnosis. New Sleep Pointe mobile sleep labs equipped by Covidien are designed to meet truckers anywhere on the road." |
|
“Top Story: Covidien, Sleep Pointe Join Forces to Help Truckers" Approximately 28% of commercial truck drivers are affected by sleep apnea. If apnea is left untreated, these transportation professionals are between two and seven times more likely to have a serious accident, according to Boulder, Colo-based Covidien, a global health care products company that is supporting the new Mobile Sleep Solution Centers (MSSCs) created by Sleep Pointe, Wichita, Kan. |
|
|
|
|
<< Start < Prev 1 2 Next > End >>
|
|
Page 1 of 2 |